Home › Canaccord Genuity Reaffirms "Buy" Rating for Regeneron Pharmaceuticals
 

Keywords :   


Canaccord Genuity Reaffirms "Buy" Rating for Regeneron Pharmaceuticals

2015-05-26 01:13:12| Biotech - Topix.net

's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a note issued to investors on Thursday. They currently have a $460.00 price target on the biopharmaceutical company's stock.

Tags: buy rating pharmaceuticals reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.11Subtropical Storm Patty Graphics
02.11Tropical Storm Lane Graphics
02.11Tropical Storm Lane Wind Speed Probabilities Number 5
02.11Tropical Storm Lane Forecast Advisory Number 5
02.11Tropical Storm Lane Public Advisory Number 5
02.11Summary for Tropical Storm Lane (EP3/EP132024)
02.11Subtropical Storm Patty Forecast Discussion Number 3
02.11Subtropical Storm Patty Wind Speed Probabilities Number 3
More »